Company intelligence / Profile preview
Shenogen Pharma Group
Beijing, Beijing Municipality/Province-level city or region as appropriate., Chinashenogen.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
The lead compound Icaritin has demonstrated clinical safety and efficacy in Phase II studies for advanced HBV-related hepatocellular carcinoma and has progressed to a Phase III trial. The company’s pipeline includes additional assets at various stages from discovery through late-stage clinical development targeting oncology indications with novel mechanisms of action.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small moleculesHerbal medicine-derived compounds (e.g., Icaritin)Oncolytic virusesAntibody-based biologics (including bispecific and trispecific antibodies)PROTACs (Proteolysis-targeting chimeras)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Collaborates extensively with key research institutions and business partners but no specific names provided in search results.
Beyond the preview
Go deeper on Shenogen Pharma Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenogen Pharma Group.